Stempeutics (India)

Recent papers from Stempeutics (India)

1. Evaluation of the binder effect of Pentadesma butyracea gum on the mechanical characteristics of paracetamol tabletsScientific African · 2025
2. Two years efficacy and safety outcomes of using allogeneic, pooled mesenchymal stromal cells for osteoarthritis of knee in a double-blind randomized placebo-controlled phase 3 studyOsteoarthritis and Cartilage Open · 2025
3. Tumor Specific Drug Delivery: Conventional to Advanced TechnologiesCritical Reviews in Therapeutic Drug Carrier Systems · 2025
4. Exosome Therapy: A Promising Avenue for Treating Intervertebral Disc DegenerationTissue Engineering and Regenerative Medicine · 2025
5. Cell and gene therapy approvals in Asia: regulatory landscape, access and affordabilityCytotherapy · 2025
6. Targeting LLT1 as a potential immunotherapy option for cancer patients non-responsive to existing checkpoint therapies in multiple solid tumorsBMC Cancer · 2024
7. Mesenchymal stromal cell therapy (REGENACIP®), a promising treatment option in chronic limb threatening ischemia – a narrative reviewStem Cell Research & Therapy · 2024
8. Therapeutic Applications of Engineered Mesenchymal Stromal Cells for Enhanced Angiogenesis in Cardiac and Cerebral IschemiaStem Cell Reviews and Reports · 2024
9. Advantages of pooling of human bone marrow-derived mesenchymal stromal cells from different donors versus single-donor MSCsScientific Reports · 2024
10. Challenges in Global Access to CAR-T cells: an Asian PerspectiveBLOOD CELL THERAPY / The official journal of APBMT · 2024
11. Efficacy and Safety of Stempeucel in Osteoarthritis of the Knee: A Phase 3 Randomized, Double-Blind, Multicenter, Placebo-Controlled StudyThe American Journal of Sports Medicine · 2023
12. Label extension, single-arm, phase III study shows efficacy and safety of stempeucel® in patients with critical limb ischemia due to atherosclerotic peripheral arterial diseaseStem Cell Research & Therapy · 2023
13. Therapeutic Approach for Hair Growth and Regeneration Using Bioactive Formulation Containing Mesenchymal Stromal Cell-Derived Conditioned MediumJournal of Cosmetics Dermatological Sciences and Applications · 2023
14. Comparison of guidelines for biological ancillary materials used for the manufacture of gene and cellular therapy products in AsiaCytotherapy · 2022
15. Nasal delivery of neurotherapeutics via nanocarriers: Facets, aspects, and prospectsFrontiers in Pharmacology · 2022
16. Opportunities in combinational chemo-immunotherapy for breast cancer using nanotechnology: an emerging landscapeExpert Opinion on Drug Delivery · 2022
17. Nonclinical and quality assessment of cell therapy products: Report on the 4th Asia Partnership Conference of Regenerative Medicine, April 15, 2021Cytotherapy · 2022
18. Phase IV Postmarketing Surveillance Study Shows Continued Efficacy and Safety of Stempeucel in Patients with Critical Limb Ischemia Due to Buerger's DiseaseStem Cells Translational Medicine · 2021
19. Stem Cells as a Potential Therapeutic Option for Treating Neurodegenerative DiseasesCurrent Stem Cell Research & Therapy · 2021
20. Non-clinical assessment of cell therapy products: the perspective from five Asian countries/regions based on regulatory guidelines and the underpinning rationalesCytotherapy · 2021